Skip to main content

Day: August 14, 2024

High Arctic Overseas Announces TSXV Final Approval and Listing Date

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, Aug. 14, 2024 (GLOBE NEWSWIRE) — High Arctic ‎Overseas Holdings Corp. (TSXV: HOH) (“High Arctic Overseas” or the “Corporation”) is pleased to announce that it has received final approval to list the common shares of the Corporation (“Common Shares”) on the TSX Venture Exchange (the “TSXV”). The Common Shares are expected to ‎commence trading on the TSXV at the market opening on August 16‎, 2024, and the CUSIP number for the ‎Common Shares will be “42964K101”. On August 12, 2024, High Arctic Energy Services Inc. (“High Arctic”) ‎and the Corporation completed the...

Continue reading

Northland Power Reports Second Quarter 2024 Results

Baltic Power, Hai Long and Oneida projects continue to make construction progress TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) reported today financial results for the three and six months ended June 30, 2024. All dollar amounts set out herein are in thousands of Canadian dollars, unless otherwise stated. “Northland’s strong performance in the second quarter has contributed to solid results for the first half of 2024, largely driven by high wind resource at our offshore wind facilities,” said John Brace, Northland’s Executive Chair. “We also continue to make progress on the construction of our two offshore wind projects in Taiwan and Poland, and our energy storage project in Canada. The execution of these three projects remains our top priority as we focus on their safe...

Continue reading

VERSES Announces NRI Transitions to GENIUS™

VANCOUVER, British Columbia, Aug. 14, 2024 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company developing next-generation intelligent software systems, today announced that third party logistics company NRI USA, LLC (“NRI”) will be upgrading to the GENIUS Beta program. “NRI was an early adopter of our offerings and saw the vision of what our intelligent software can provide. Since we entered into a commercial agreement with them, our business model has evolved from an industry specific bespoke offering, to that of our current flagship platform offering, GENIUS. So naturally it makes sense to transition our relationship onto the GENIUS platform,” said Gabriel René, CEO of VERSES. “It was great utilizing the early capabilities of Wayfinder but we need more than just...

Continue reading

Euro Manganese Reports Third Fiscal Quarter 2024 Financial Results

VANCOUVER, British Columbia, Aug. 14, 2024 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQB: EUMNF; Frankfurt: E06) (the “Company” or “EMN”) today announced financial results and key developments during the third fiscal quarter and to date. The Company has now filed its June 30, 2024, third fiscal quarter Financial Statements and Management’s Discussion and Analysis. Euro Manganese’s fiscal year end is September 30. Key Developments During and Subsequent to the Quarter Chvaletice Project, Czech Republic Successful completion of commissioning of the Company’s high-purity manganese Demonstration Plant at its Chvaletice Manganese Project (“Chvaletice Project” or the “Project”), allowing for the production of bulk, multi-tonne finished product samples of high-purity...

Continue reading

Intermap Announces 125% Revenue Growth in the Second Quarter

Revenue jumped to $3.6 million from $1.6 million last year $0.9 million of EBITDA, $0.6 million of operating income and $0.6 million of net income Airborne platform commenced data collection for the Indonesian mapping program Affirming 2024 revenue projections of $16-18 million, adjusted EBITDA margin of approximately 25% DENVER, Aug. 14, 2024 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced 125% revenue growth in the second quarter of 2024. For the period ending June 30, 2024, the Company reported revenue of $3.6 million compared with $1.6 million for the second quarter of 2023. Following a successful technology upgrade, and re-certification of its sensor payload and airborne platform to meet world-leading...

Continue reading

Quipt Home Medical Reports Third Quarter Fiscal 2024 Financial Results

CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2024, and are reported in United States dollars (“$”, “dollars” and “US$”) and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, August 15, 2024, at 10:00 a.m. (ET). The dial-in number is 1 (844) 763 8274 or 1 (647) 484 8814. The live audio webcast can be found on the investor section of the Company’s website through the following link: www.quipthomemedical.com. Financial Highlights: Revenue...

Continue reading

Cancellation of Subsequent Offering in IDEX Biometrics

Reference is made to the stock exchange notice on 15 May 2024 regarding the completion of a private placement and a potential subsequent offering on the same terms and conditions as in the private placement, directed towards eligible shareholders. The board of directors of IDEX Biometrics has decided not to proceed with the subsequent offering. The background for the cancellation is that the company’s shares have traded below the subscription price in the private placement for a substantial period and at sufficient volumes. Shareholders wishing to reduce the dilutive effect of the private placement have therefore had the opportunity to purchase shares in the market at prices below the price which would have been the subscription price in the subsequent offering. For further information contact: Marianne Bøe, Head of Investor RelationsE-mail:...

Continue reading

Edward Rogers appointed Executive Chair of Rogers Communications

TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) — Rogers Board of Directors today appointed Edward Rogers Executive Chair of Rogers Communications effective immediately.  “This appointment simply recognizes the role Edward is performing at the company,” said Robert J. Gemmell, Lead Director. “The company has never been stronger thanks to Tony’s leadership and Edward’s stewardship. Today’s appointment merely formalizes Edward’s role.” Edward Rogers will continue to lead the Board as Executive Chair. Working with the Board and the Chief Executive Officer, Rogers will lead the development and review of the company’s long-term strategy for growth. Tony Staffieri’s responsibilities as Chief Executive Officer remain the same. Reporting to the full Rogers board, Staffieri will continue to run the company. “The past...

Continue reading

Actelis Networks Reports Q2 2024 Results: 372% Sequential Revenue Growth, 81% Year-Over-Year Increase, and Positive EBITDA

Actelis Networks achieves very strong Q2 2024 performance with 372% sequential revenue growth, 81% year-over-year revenue increase, and positive EBITDA, highlighting strong execution and financial discipline FREMONT, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today reported financial results for the fiscal second quarter ended June 30, 2024. Second Quarter and First Half 2024 Financial Highlights: Major Revenue Growth: Actelis achieved revenue increase to $3.43 million in Q2 2024, reflecting an 81% year-over-year growth compared to $1.9 million in Q2 2023, and 372% sequential growth from $0.73 million in Q1 2024, driven by the accelerated execution of large contracts,...

Continue reading

Avicanna Reports Q2 2024

Q2 2024 revenue of $6.1 million an increase of 85% over Q2 2023Completion of two real world evidence trials on Epidermolysis Bullosa and Musculoskeletal Pain TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products reports the results of Q2 2024. “We are happy to deliver another progressive quarter where we solidified our position in the medical cannabis space, enhanced relationships with the medical community, and stabilized our commercial operations in Canada. In addition, we are happy to report that during the second quarter, we saw the completion of two separate real world evidence trials focused on two of our drug candidates in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.